F420 dependent glucose-6-phosphate dehydrogenase (FGD), although originally discovered in Nocardia, has been extensively studied in Mycobacteria due to the health relevance for tuberculosis (TB) treatment. FGD catalyzes the conversion of glucose-6-phosphate (G6P) to 6-phosphogluconolactone, using oxidized F420 cofactor, which becomes reduced during catalysis. The focus of this project is on FGD from Nocardioidaceae bacterium (FGD-Noca), which shows activity towards additional sugar-6-phosphates, such as glucose-6-phosphate (G6P), D-mannose-6-phosphate (M6P), and D-fructose-6-phosphate (F6P), unlike the mycobacterial enzyme which only displays specificity towards G6P. The major goal of our research is to characterize the FSDs using steady-state and pre steady-state kinetic methods to provide detailed mechanistic insights for the FSDs. Our initial goal of this project is to express and purify FGD-Noca in order to kinetically characterize the hydride transfer reaction mechanism of wtFGD-Noca. The proposed experiments and preliminary results will be described here. Our project is currently funded by WELCH foundation.
No takes yet. Share an insight, caveat, or question.
Ahamed et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: